Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.62 | 51.77 |
| PEG Ratio (TTM) | -0.36 | 8.83 |
| P/S Ratio (TTM) | 1.18 | 16.90 |
| P/B Ratio (TTM) | 1.03 | 16.88 |
| P/FCF Ratio (TTM) | -2.94 | 50.52 |
| Price to 5YR AVG Earnings Ratio | 9.23 | 10.22 |
| Price to 5YR AVG FCF Ratio | 46.06 | 56.84 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.97% | 12.58% |
| ROE (TTM) | 13.73% | 57.13% |
| Net Profit Margin (TTM) | 16.69% | 25.08% |
| ROIC 5YR AVG | 16.04% | -25.18% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -12.25% | -28.61% | 71.35% |
| Revenue | 2.22% | 44.41% | 51.25% |
| Net Income | 14.60% | -30.52% | 74.53% |
| Cash Flow | -274.44% | 2,126.02% | 1,264.52% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.42 | 1.61 |
| Quick Ratio (TTM) | 1.42 | 1.59 |
| D/E Ratio (TTM) | 0.66 | 0.85 |
| Interest Coverage (TTM) | 0.60 | 55.84 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.84 | 12.89 |
| LTL to 5YR AVG FCF | 71.17 | 4.02 |
| Shares Outstanding Growth 5YR AVG | 3.97% | 2.65% |